Fabrice André, MD, PhD, discusses strategies to improve outcomes in patients with breast cancer.
Fabrice André, MD, PhD, professor of Medical Oncology at the Institut Gustave Roussy in Villejuif, France, discusses strategies to improve outcomes in patients with breast cancer.
At the 2020 ESMO Breast Cancer Virtual Meeting, André spoke to 4 research priorities in the field of breast cancer.
One of these priorities is to improve patient outcomes as they pertain to overall survival and disease-free survival, explains André.
One strategy to move toward improving these outcomes is to develop a biological model of each patient’s disease to determine the molecular mechanisms that contribute to their progression, says André.
Additionally, developing novel biotechnologies to identify new agents could translate into improved outcomes, says André.
For example, using new biotechnologies to create improved linkers for antibody-drug conjugates is being done currently in breast cancer, concludes André.